Quantcast

Latest Instituto de Medicina Molecular Stories

2014-04-01 14:28:49

Experts analyze baker's yeast to discover potential for combating neurological conditions like Parkinson's and even cancer A humble ingredient of bread – baker's yeast – has provided scientists with remarkable new insights into understanding basic processes likely involved in diseases such as Parkinson's and cancer. In a new study published today (Monday March 31) in the prestigious journal PNAS (Proceedings of the National Academy of Science), the team from Germany, Leicester, and...

regeneration of zebrafish fin
2014-03-30 06:37:34

Instituto Gulbenkian de Ciencia The reason why some animals can regenerate tissues after severe organ loss or amputation while others, such as humans, cannot renew some structures has always intrigued scientists. In a study now published in PLOS ONE, a research group from Instituto Gulbenkian de Ciência (IGC, Portugal) led by Joaquín Rodríguez León provided new clues to solve this central question by investigating regeneration in an adult vertebrate model: the zebrafish. It was known...

2011-05-16 14:24:58

Study will be published in Nature Medicine this Sunday, May 15, and may have impact in the fight against the disease A team of researchers have found that pre-existing malaria prevents secondary infection by another Plasmodium strain, the parasite responsible for malaria, by restricting iron availability in the liver of the host. This discovery will be published this Sunday, May 15, in Nature Medicine and has important implications for the management and prevention of malaria, a condition...

2008-11-11 09:00:47

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Cenix BioScience GmbH, a leading RNAi-focused contract research organization, today announced the publication of a new study in the journal PLoS Pathogens demonstrating in vitro and in vivo RNAi-mediated silencing of novel host factors involved in malaria infection. The work resulted from an ongoing malaria research program started as a collaboration announced in 2005 between the group of Dr. Maria Mota at...

2008-09-11 09:00:48

Cenix BioScience GmbH, a leading specialist in advanced RNA interference (RNAi)-based research services, Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and the Lisbon-based biomedical research centre Instituto de Medicina Molecular (IMM), today announced the publication of their collaborative study in Cell Host & Microbe, describing the discovery and in vivo validation of scavenger receptor BI (SR-BI), a major regulator of cholesterol uptake by the...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related